| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Diseases | 3 | 2023 | 553 | 0.720 |
Why?
|
| Orchitis | 1 | 2018 | 35 | 0.620 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2018 | 41 | 0.600 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 47 | 0.590 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 710 | 0.550 |
Why?
|
| Spinal Cord Diseases | 2 | 2017 | 292 | 0.460 |
Why?
|
| Spinal Cord | 6 | 2017 | 1818 | 0.420 |
Why?
|
| Pinealoma | 2 | 2008 | 52 | 0.380 |
Why?
|
| Fever | 1 | 2018 | 1618 | 0.360 |
Why?
|
| Myelinolysis, Central Pontine | 2 | 2009 | 17 | 0.340 |
Why?
|
| Decerebrate State | 1 | 2009 | 42 | 0.340 |
Why?
|
| Vascular Diseases | 2 | 2017 | 1161 | 0.330 |
Why?
|
| Intracranial Arterial Diseases | 1 | 2009 | 22 | 0.320 |
Why?
|
| Osmotic Pressure | 1 | 2009 | 138 | 0.320 |
Why?
|
| Brain Infarction | 2 | 2009 | 290 | 0.290 |
Why?
|
| Hyponatremia | 1 | 2009 | 279 | 0.270 |
Why?
|
| Central Nervous System Diseases | 5 | 1997 | 520 | 0.270 |
Why?
|
| Pituitary Neoplasms | 4 | 2019 | 1324 | 0.260 |
Why?
|
| Fatal Outcome | 7 | 2018 | 1834 | 0.250 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2006 | 263 | 0.240 |
Why?
|
| Neuroma | 1 | 2006 | 133 | 0.230 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2014 | 301 | 0.230 |
Why?
|
| Sodium | 1 | 2009 | 1588 | 0.220 |
Why?
|
| Brain Neoplasms | 12 | 2016 | 9031 | 0.190 |
Why?
|
| Brain | 16 | 2017 | 27112 | 0.190 |
Why?
|
| AIDS Dementia Complex | 3 | 2017 | 153 | 0.180 |
Why?
|
| Pituitary Diseases | 2 | 2019 | 135 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 6 | 2003 | 2199 | 0.180 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2010 | 2790 | 0.180 |
Why?
|
| Carbon Dioxide | 1 | 2005 | 1147 | 0.180 |
Why?
|
| Pineal Gland | 3 | 2008 | 158 | 0.180 |
Why?
|
| Methanol | 1 | 2001 | 92 | 0.180 |
Why?
|
| Putamen | 1 | 2001 | 292 | 0.170 |
Why?
|
| Granular Cell Tumor | 1 | 2019 | 48 | 0.170 |
Why?
|
| JC Virus | 3 | 2006 | 87 | 0.160 |
Why?
|
| Sciatic Nerve | 3 | 2014 | 617 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 2727 | 0.160 |
Why?
|
| Neurilemmoma | 1 | 2024 | 526 | 0.160 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 3 | 2006 | 133 | 0.160 |
Why?
|
| Mutation, Missense | 3 | 2017 | 2571 | 0.150 |
Why?
|
| Ependymoma | 3 | 2008 | 320 | 0.150 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1997 | 44 | 0.140 |
Why?
|
| Meningeal Neoplasms | 2 | 2024 | 1248 | 0.140 |
Why?
|
| Leukemia, Plasma Cell | 1 | 2017 | 46 | 0.140 |
Why?
|
| Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
| Wallerian Degeneration | 1 | 2017 | 68 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 256 | 0.140 |
Why?
|
| Neurocytoma | 1 | 2016 | 29 | 0.140 |
Why?
|
| Nerve Block | 3 | 2014 | 706 | 0.130 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2017 | 100 | 0.130 |
Why?
|
| Endocrine System Diseases | 1 | 1998 | 249 | 0.130 |
Why?
|
| Sensation Disorders | 1 | 1997 | 160 | 0.130 |
Why?
|
| Meningioma | 2 | 2024 | 1218 | 0.130 |
Why?
|
| Neuromuscular Diseases | 2 | 2014 | 258 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 263 | 0.120 |
Why?
|
| Teratoma | 2 | 2014 | 404 | 0.120 |
Why?
|
| History, 19th Century | 1 | 2017 | 720 | 0.120 |
Why?
|
| Facial Injuries | 1 | 2015 | 190 | 0.110 |
Why?
|
| Mobius Syndrome | 1 | 2013 | 41 | 0.110 |
Why?
|
| Malignant Hyperthermia | 1 | 2013 | 71 | 0.110 |
Why?
|
| Interferons | 1 | 2017 | 706 | 0.110 |
Why?
|
| Facial Transplantation | 1 | 2015 | 221 | 0.110 |
Why?
|
| Neuroglia | 4 | 2006 | 956 | 0.110 |
Why?
|
| Biopsy | 3 | 2023 | 6766 | 0.100 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2013 | 182 | 0.100 |
Why?
|
| Neurofilament Proteins | 1 | 2014 | 336 | 0.100 |
Why?
|
| Nissl Bodies | 1 | 1992 | 16 | 0.100 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 210 | 0.100 |
Why?
|
| Cervical Vertebrae | 2 | 2010 | 980 | 0.100 |
Why?
|
| Contrast Media | 1 | 2005 | 5311 | 0.100 |
Why?
|
| Amyloid | 1 | 2017 | 841 | 0.100 |
Why?
|
| Brain Ischemia | 1 | 2005 | 3049 | 0.100 |
Why?
|
| Anesthetics, Local | 3 | 2009 | 997 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 2014 | 405 | 0.090 |
Why?
|
| Seizures | 2 | 2017 | 2957 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2017 | 1567 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2010 | 638 | 0.090 |
Why?
|
| Glioma | 5 | 2010 | 3455 | 0.090 |
Why?
|
| Humans | 64 | 2024 | 761504 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 2 | 2001 | 2656 | 0.090 |
Why?
|
| Hypoxia, Brain | 2 | 2009 | 138 | 0.080 |
Why?
|
| Cerebral Arteries | 2 | 2009 | 490 | 0.080 |
Why?
|
| Diencephalon | 1 | 2009 | 54 | 0.080 |
Why?
|
| Skin | 1 | 2023 | 4484 | 0.080 |
Why?
|
| Circle of Willis | 1 | 2009 | 78 | 0.080 |
Why?
|
| Headache | 1 | 2017 | 1256 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1589 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2017 | 2767 | 0.080 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2008 | 60 | 0.080 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 1897 | 0.080 |
Why?
|
| Astrocytoma | 2 | 2004 | 775 | 0.080 |
Why?
|
| Pons | 1 | 2009 | 240 | 0.070 |
Why?
|
| Nervous System | 1 | 2011 | 545 | 0.070 |
Why?
|
| Nitrosourea Compounds | 1 | 2007 | 32 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 1992 | 748 | 0.070 |
Why?
|
| Astrocytes | 4 | 2005 | 1346 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20570 | 0.070 |
Why?
|
| Stathmin | 1 | 2007 | 70 | 0.070 |
Why?
|
| Dementia, Vascular | 1 | 2008 | 122 | 0.070 |
Why?
|
| Diagnosis, Differential | 7 | 2017 | 12974 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1935 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 459 | 0.070 |
Why?
|
| Adenoma | 1 | 2016 | 2160 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 539 | 0.060 |
Why?
|
| Lidocaine | 1 | 2009 | 538 | 0.060 |
Why?
|
| Vomiting | 1 | 2009 | 651 | 0.060 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2010 | 611 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2007 | 3769 | 0.060 |
Why?
|
| Male | 38 | 2019 | 360804 | 0.060 |
Why?
|
| Oligodendroglioma | 1 | 2007 | 279 | 0.060 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Injections, Intra-Arterial | 1 | 2005 | 182 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 189 | 0.060 |
Why?
|
| Encephalitis | 4 | 1999 | 438 | 0.060 |
Why?
|
| Myelin Sheath | 1 | 2009 | 653 | 0.060 |
Why?
|
| Doxepin | 1 | 2004 | 16 | 0.060 |
Why?
|
| Amitriptyline | 1 | 2004 | 112 | 0.060 |
Why?
|
| Adult | 28 | 2020 | 221177 | 0.060 |
Why?
|
| Opportunistic Infections | 2 | 2001 | 376 | 0.060 |
Why?
|
| Mononeuropathies | 1 | 2003 | 13 | 0.060 |
Why?
|
| Bupivacaine | 2 | 2004 | 412 | 0.060 |
Why?
|
| Syndrome | 2 | 2009 | 3267 | 0.060 |
Why?
|
| Female | 37 | 2020 | 392644 | 0.060 |
Why?
|
| Eye Diseases | 1 | 1989 | 653 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2008 | 491 | 0.050 |
Why?
|
| Neurons | 4 | 2005 | 9463 | 0.050 |
Why?
|
| Thalamus | 1 | 2009 | 1045 | 0.050 |
Why?
|
| Myopathies, Nemaline | 1 | 2003 | 73 | 0.050 |
Why?
|
| Myositis | 1 | 2005 | 271 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 481 | 0.050 |
Why?
|
| Animals | 10 | 2018 | 168459 | 0.050 |
Why?
|
| Middle Aged | 20 | 2019 | 220895 | 0.050 |
Why?
|
| Axons | 1 | 2010 | 1674 | 0.050 |
Why?
|
| Nerve Fibers | 1 | 2006 | 708 | 0.050 |
Why?
|
| Progestins | 1 | 2024 | 301 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2005 | 553 | 0.050 |
Why?
|
| Putaminal Hemorrhage | 1 | 2001 | 5 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2004 | 370 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 2561 | 0.050 |
Why?
|
| Medulloblastoma | 1 | 2006 | 678 | 0.050 |
Why?
|
| BK Virus | 1 | 2001 | 123 | 0.050 |
Why?
|
| Child | 13 | 2016 | 80153 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2005 | 941 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 2006 | 960 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2006 | 1393 | 0.040 |
Why?
|
| Cognition Disorders | 2 | 2020 | 3979 | 0.040 |
Why?
|
| Brain Diseases | 4 | 2005 | 1545 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2005 | 822 | 0.040 |
Why?
|
| Aging | 2 | 2015 | 8708 | 0.040 |
Why?
|
| Lyme Disease | 1 | 2005 | 631 | 0.040 |
Why?
|
| Polyomavirus Infections | 1 | 2001 | 194 | 0.040 |
Why?
|
| Cerebral Angiography | 1 | 2005 | 1281 | 0.040 |
Why?
|
| Neoplasms, Fibrous Tissue | 1 | 1999 | 20 | 0.040 |
Why?
|
| Immunohistochemistry | 6 | 2008 | 11076 | 0.040 |
Why?
|
| Pedigree | 3 | 2014 | 4542 | 0.040 |
Why?
|
| Steroids | 1 | 2024 | 929 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2001 | 438 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 916 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 240 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4915 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2015 | 15631 | 0.040 |
Why?
|
| Dementia | 1 | 1992 | 2686 | 0.040 |
Why?
|
| Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 283 | 0.030 |
Why?
|
| Myotonia | 1 | 1996 | 18 | 0.030 |
Why?
|
| Child, Preschool | 9 | 2016 | 42230 | 0.030 |
Why?
|
| Cauda Equina | 1 | 1996 | 45 | 0.030 |
Why?
|
| Necrosis | 1 | 2001 | 1611 | 0.030 |
Why?
|
| Infant | 7 | 2016 | 36192 | 0.030 |
Why?
|
| Cerebellum | 1 | 2003 | 1501 | 0.030 |
Why?
|
| Genotype | 4 | 2014 | 12990 | 0.030 |
Why?
|
| Giant Cells | 1 | 1996 | 188 | 0.030 |
Why?
|
| Gliosis | 1 | 2017 | 245 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 11121 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 1998 | 486 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 2917 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2017 | 441 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 1995 | 82 | 0.030 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1996 | 133 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 1560 | 0.030 |
Why?
|
| Swine | 1 | 2005 | 5915 | 0.030 |
Why?
|
| Rats | 5 | 2014 | 23742 | 0.030 |
Why?
|
| Colchicine | 1 | 1996 | 259 | 0.030 |
Why?
|
| Electromyography | 2 | 2017 | 1394 | 0.030 |
Why?
|
| Anisotropy | 2 | 2010 | 1283 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2009 | 8181 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2014 | 131 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 726 | 0.030 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1998 | 389 | 0.030 |
Why?
|
| Neurophysins | 1 | 1993 | 14 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2017 | 36426 | 0.030 |
Why?
|
| Hepatic Encephalopathy | 1 | 1995 | 144 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 1666 | 0.030 |
Why?
|
| Sella Turcica | 1 | 1994 | 118 | 0.030 |
Why?
|
| Mutation | 3 | 2014 | 30052 | 0.030 |
Why?
|
| Synaptophysin | 1 | 1993 | 139 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1999 | 829 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 1999 | 852 | 0.030 |
Why?
|
| Nervous System Neoplasms | 1 | 1993 | 91 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2013 | 236 | 0.030 |
Why?
|
| Proprioception | 2 | 2004 | 133 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 9000 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 1998 | 727 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17904 | 0.030 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 122 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 307 | 0.030 |
Why?
|
| Cadaver | 1 | 1997 | 1358 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2009 | 4420 | 0.030 |
Why?
|
| Ophthalmoplegia | 1 | 2013 | 168 | 0.030 |
Why?
|
| Blepharoptosis | 1 | 2013 | 144 | 0.030 |
Why?
|
| Gemfibrozil | 1 | 1992 | 30 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4580 | 0.030 |
Why?
|
| Hamartoma | 1 | 1994 | 235 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5305 | 0.020 |
Why?
|
| DNA Polymerase III | 1 | 1992 | 51 | 0.020 |
Why?
|
| Consanguinity | 1 | 2013 | 456 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2013 | 446 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2017 | 870 | 0.020 |
Why?
|
| Insomnia, Fatal Familial | 1 | 2011 | 2 | 0.020 |
Why?
|
| Lovastatin | 1 | 1992 | 115 | 0.020 |
Why?
|
| Prognosis | 6 | 2014 | 29625 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2016 | 80636 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 544 | 0.020 |
Why?
|
| HIV-1 | 2 | 2006 | 6863 | 0.020 |
Why?
|
| Cell Movement | 2 | 2006 | 5203 | 0.020 |
Why?
|
| Muscles | 2 | 1996 | 1576 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 2571 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2003 | 4948 | 0.020 |
Why?
|
| Adolescent | 9 | 2016 | 88319 | 0.020 |
Why?
|
| Cytodiagnosis | 1 | 2014 | 447 | 0.020 |
Why?
|
| Ubiquitins | 1 | 1992 | 366 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1474 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1999 | 2244 | 0.020 |
Why?
|
| Incidence | 1 | 2008 | 21353 | 0.020 |
Why?
|
| Action Potentials | 1 | 2017 | 1834 | 0.020 |
Why?
|
| Survival Rate | 4 | 2008 | 12725 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1738 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 1776 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2006 | 9606 | 0.020 |
Why?
|
| Biological Clocks | 1 | 2011 | 318 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1705 | 0.020 |
Why?
|
| Behavior, Animal | 2 | 2009 | 1878 | 0.020 |
Why?
|
| Drug Implants | 1 | 2009 | 230 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 662 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2010 | 712 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 1423 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 794 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 39106 | 0.020 |
Why?
|
| Sleep, REM | 1 | 2011 | 595 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3332 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1998 | 4003 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 5671 | 0.020 |
Why?
|
| Neuroendocrine Tumors | 1 | 1993 | 641 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 11903 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1091 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 283 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2011 | 694 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 2005 | 5777 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 59243 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2049 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2001 | 4234 | 0.020 |
Why?
|
| Antigens | 1 | 1992 | 1443 | 0.020 |
Why?
|
| Inclusion Bodies, Viral | 2 | 2003 | 45 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2011 | 999 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2005 | 93 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 4615 | 0.020 |
Why?
|
| Aged | 8 | 2017 | 169289 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2011 | 944 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2006 | 262 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4111 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2006 | 211 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9280 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2006 | 441 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 5796 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2008 | 503 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 2880 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10766 | 0.010 |
Why?
|
| Kidney | 2 | 2001 | 7048 | 0.010 |
Why?
|
| Cell Nucleus | 2 | 2004 | 2909 | 0.010 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2010 | 938 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8529 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 750 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2010 | 1768 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2606 | 0.010 |
Why?
|
| Wakefulness | 1 | 2011 | 1265 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2004 | 318 | 0.010 |
Why?
|
| Body Weight | 1 | 2014 | 4618 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2010 | 3606 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1992 | 2303 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1995 | 2330 | 0.010 |
Why?
|
| Sodium Channel Blockers | 1 | 2004 | 173 | 0.010 |
Why?
|
| Algorithms | 3 | 2010 | 14031 | 0.010 |
Why?
|
| Tropomyosin | 1 | 2003 | 104 | 0.010 |
Why?
|
| Choline | 1 | 2004 | 515 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 1342 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 629 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2819 | 0.010 |
Why?
|
| Creatine | 1 | 2004 | 427 | 0.010 |
Why?
|
| Glycogen | 1 | 2003 | 251 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 2004 | 576 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 2004 | 281 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2004 | 339 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1835 | 0.010 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1087 | 0.010 |
Why?
|
| Time Factors | 4 | 2006 | 39967 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1405 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 1745 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2008 | 1475 | 0.010 |
Why?
|
| Virus Activation | 1 | 2003 | 322 | 0.010 |
Why?
|
| Protons | 1 | 2007 | 1116 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2006 | 1089 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2003 | 284 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2008 | 1499 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17635 | 0.010 |
Why?
|
| Lymphoma | 1 | 1990 | 1901 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2510 | 0.010 |
Why?
|
| Capsid | 1 | 2003 | 435 | 0.010 |
Why?
|
| Autopsy | 2 | 1996 | 1008 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2872 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1416 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 11460 | 0.010 |
Why?
|
| Apoptosis | 1 | 1996 | 9486 | 0.010 |
Why?
|
| Lamins | 1 | 1999 | 37 | 0.010 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 1999 | 21 | 0.010 |
Why?
|
| Nociceptors | 1 | 2004 | 461 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 14666 | 0.010 |
Why?
|
| Cell Death | 1 | 2005 | 1678 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2014 | 6391 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 1900 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 542 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2017 | 26198 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2003 | 538 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2004 | 1139 | 0.010 |
Why?
|
| Vasculitis | 1 | 2003 | 521 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1675 | 0.010 |
Why?
|
| North America | 1 | 2003 | 1276 | 0.010 |
Why?
|
| Australia | 1 | 2003 | 1250 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 1510 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2295 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 6965 | 0.010 |
Why?
|
| Endothelium | 1 | 2001 | 765 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 16981 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2919 | 0.010 |
Why?
|
| Lamin Type A | 1 | 1999 | 189 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 1967 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2001 | 412 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4920 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 6132 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1992 | 3839 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4575 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 6814 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 1517 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6484 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2001 | 662 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2005 | 2203 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2226 | 0.010 |
Why?
|
| Edema | 1 | 2001 | 766 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 6343 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4853 | 0.010 |
Why?
|
| HIV Infections | 2 | 1996 | 17351 | 0.010 |
Why?
|
| Confusion | 1 | 1999 | 278 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1994 | 4876 | 0.010 |
Why?
|
| Metabolic Diseases | 1 | 2003 | 683 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2072 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1999 | 852 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3778 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16591 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2003 | 2202 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 1999 | 658 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1996 | 237 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1902 | 0.010 |
Why?
|
| Disease Progression | 2 | 2003 | 13506 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12441 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2005 | 18965 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6228 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 2435 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 2050 | 0.010 |
Why?
|
| Infectious Mononucleosis | 1 | 1975 | 133 | 0.010 |
Why?
|
| Sleep | 1 | 2011 | 4768 | 0.010 |
Why?
|
| Keratins | 1 | 1996 | 498 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 6863 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1999 | 1699 | 0.010 |
Why?
|
| Eosinophils | 1 | 1999 | 950 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1995 | 698 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 2715 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 1784 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 23995 | 0.010 |
Why?
|
| Lipoma | 1 | 1976 | 293 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 2265 | 0.010 |
Why?
|
| Macrophages | 2 | 1999 | 5769 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1994 | 218 | 0.010 |
Why?
|
| Meningitis | 1 | 1995 | 217 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 4414 | 0.010 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 1993 | 136 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2005 | 5112 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 5972 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1994 | 436 | 0.010 |
Why?
|
| Myelitis | 1 | 1992 | 49 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 12463 | 0.010 |
Why?
|
| Mast Cells | 1 | 1999 | 1392 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1992 | 12128 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 18395 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2003 | 3060 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1999 | 1993 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2008 | 64680 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 14414 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1994 | 483 | 0.010 |
Why?
|
| Brain Edema | 1 | 1995 | 604 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 7396 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 12795 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 4726 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 9420 | 0.010 |
Why?
|
| Fatty Liver | 1 | 1995 | 790 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10445 | 0.010 |
Why?
|
| Microglia | 1 | 1998 | 1361 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 4740 | 0.000 |
Why?
|
| Mice | 2 | 2006 | 81525 | 0.000 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1992 | 547 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 58976 | 0.000 |
Why?
|
| Pediatrics | 1 | 2003 | 3589 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15266 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 13446 | 0.000 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 4527 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 15842 | 0.000 |
Why?
|
| Age of Onset | 1 | 1994 | 3305 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 22169 | 0.000 |
Why?
|
| Inflammation | 1 | 2006 | 10773 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1999 | 4758 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18252 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 4431 | 0.000 |
Why?
|
| Cause of Death | 1 | 1995 | 3683 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13639 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2471 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1995 | 1964 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1998 | 6225 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 10194 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1992 | 6310 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1992 | 4174 | 0.000 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 1975 | 26 | 0.000 |
Why?
|
| Measles virus | 1 | 1975 | 67 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1996 | 8599 | 0.000 |
Why?
|
| Measles | 1 | 1975 | 183 | 0.000 |
Why?
|
| Sex Factors | 1 | 1976 | 10552 | 0.000 |
Why?
|
| Lung | 1 | 1975 | 10000 | 0.000 |
Why?
|